Ebovir Biotechnologie Inc. is a biotech company focused on AI-powered precision medicine. Incubated at McGill University, Ebovir’s precision medicine services are already supporting over 150 high-end health and chronic disease management centers, family practices, OB/GYN and physical exam clinics, and dental clinics across Canada, forming a robust and growing clinical partner network.
​
Through Whole Genome Sequencing (WGS) and early cancer screening, we empower physicians and healthcare providers to identify pathogenic genetic variants and pinpoint actionable targets associated with cancer, metabolic disorders, rare diseases, and more. This enables more informed prevention strategies, targeted therapeutics, and long-term personalized care planning.
​
With our state-of-the-art BSL-certified lab in Montreal, a leading AI-powered genomic analysis platform, and a global clinical research network, Ebovir is advancing a new era of integrated healthcare built on the synergy of AI + Genomics + Cell Therapy—turning your unique genetic blueprint into a powerful tool for lifelong health.